Gradient Investments LLC Charles River Laboratories International, Inc. Transaction History

Gradient Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$206.39 - $268.73 $4,127 - $5,374	20 New	20 $4,000
Q3 2023 Oct 27, 2023	BUY	$194.44 - $217.61 $972 - $1,088	5 New	5 $0
Q1 2023 Apr 17, 2023	SELL	$191.89 - $259.92 $34,348 - $46,525	-179 Reduced 94.71%	10 $2,000
Q4 2022 Jan 10, 2023	BUY	$197.11 - $250.07 $36,662 - $46,513	186 Added 6200.0%	189 $0
Q3 2022 Oct 14, 2022	BUY	$182.44 - $250.54 $547 - $751	3 New	3 $1,000
Q2 2022 Jul 11, 2022	SELL	$204.13 - $302.4 $2,857 - $4,233	-14 Closed	0 $0
Q1 2022 May 26, 2022	SELL	$255.51 - $362.11 $1,022 - $1,448	-4 Reduced 22.22%	14 $4,000
Q4 2021 Jan 12, 2022	BUY	$351.38 - $448.68 $4,919 - $6,281	14 Added 350.0%	18 $7,000
Q3 2021 Oct 18, 2021	BUY	$372.64 - $458.3 $1,490 - $1,833	4 New	4 $2,000

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.